...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
Medicine Products:(Date:10/10/2008)... BEDFORD, Mass., Oct. 10 /PRNewswire-FirstCall/...loper, manufacturer and supplier of premium,diagno...ts dedicated to,serving the healthcare needs of wo...uarter and fiscal 2008 operating results on Tuesda...ction with the release, management will,host a con...
(Date:10/10/2008)... PARK CITY, Utah, Oct. 10 /PRNewswire/ -- NuVie... management of Trace Life Sciences Inc.,(Trace), i...cyclotron,production facilities in Denton, Texas. ... Indium-111, Iodine-123 and Thallium-201 used in,m... NuView Chairman and,CEO, stated that "We are conf...
(Date:10/10/2008)... Coach Holly Warlick Teams Up with Legal and Me...rst-Ever Cancer and Careers Seminar in,Knoxville, ...gnition of National,Breast Cancer Awareness Month,... have joined forces with YWCA Knoxville, The Welln...ocate Holly Warlick, University of Tennessee,women...
(Date:10/10/2008)... The Healthcare Technolog...Care , Exton, PA (PRWEB) ...Valley Chapters of the national Healthcare Informa...ned forces to bring regional health information te...onal conference entitled The Healthcare Technology...
Breaking Medicine News(10 mins):Health News:Hologic, Inc. To Release Fourth Quarter and Fiscal 2008 Operating Results on Tuesday, November 11, 2008 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 3Health News:Local Experts Help Women Living and Working with Cancer Even the Score 4Health News:HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference 2(Date:10/8/2008)... Findings Confirm Potency of Poly-ICR as...FirstCall/ -- Nventa Biopharmaceuticals,Corporatio...eclinical,studies using its proprietary Toll-like ...R), at the World Vaccine Congress 2008 in Lyon, Fr...potent vaccine adjuvant,targeting the Toll-like Re...
(Date:10/7/2008)... FLINT, Mich., Oct. 7 /- McLaren ...re gathering some of the world,s leading medical,m...globe on breast and,gastrointestinal cancer treatm...n and GLCI, was organized by McLaren,s Sukamal Sah...e work in sentinel node mapping for,colorectal can...
(Date:10/7/2008)... VANCOUVER, Oct. 7 / Bu...d today that its Puratein(R) and,Supertein(TM) can...d As,Safe) for their intended use in a variety of ...been self-affirmed GRAS through an,independent eva...lds of,food safety, toxicology, nutritional scienc...
(Date:10/7/2008)... FORT COLLINS, Colo., Oct. 7 /- A...examining embryonic stem cell self-renewal,report...lastim (recombinant,human serum albumin) was an ef...cell culture., The article entitled, "The ground ...sed that researchers used Cellastim as a recombina...
Breaking Medicine Technology:Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5News Media Advisory: World's Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments 2Burcon announces GRAS status for Puratein(R) & Supertein(TM) 2Burcon announces GRAS status for Puratein(R) & Supertein(TM) 3Nobel Prize Awarded to Foundation for Biomedical Research Board Member 486 1Nobel Prize Awarded to Foundation for Biomedical Research Board Member 486 2Increase in ethanol production from corn could significantly impact 749 1Increase in ethanol production from corn could significantly impact 749 2Increase in ethanol production from corn could significantly impact 749 3EPI Says California Health Care Reform Bill is Misguided 3346 1DuPont Pledges 24250 000 to Nature Conservancy for Water Quality Initiative 3341 1DuPont Pledges 24250 000 to Nature Conservancy for Water Quality Initiative 3341 2DuPont Pledges 24250 000 to Nature Conservancy for Water Quality Initiative 3341 3DuPont Pledges 24250 000 to Nature Conservancy for Water Quality Initiative 3341 4...ved at Eight Weeks Sustained up to 12 Weeks,and Dr...SCO, Calif., July 02, 2007,/PRNewswire-FirstCall/ ...r-term, follow-up results from a Phase 2 study sho... 4975) in patients with,moderate-to-severe osteoar...s in pain that persisted for up to 12 weeks. , "Th...
...2, 2007-Women with at least three sites of,cellula...ore likely,than average women to develop breast ca...r Center led study of women with atypical,hyperpla...e of the,Journal of Clinical Oncology., Several pr...a,(also called atypia) in breast tissue is a major...
Other Medicine Technology:Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain,Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the,Knee 2Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain,Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the,Knee 3Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain,Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the,Knee 4Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain,Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the,Knee 5Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast,Cancer Risk Prediction in Women with Atypia 2Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast,Cancer Risk Prediction in Women with Atypia 3